Analytical Data
-
Gene name
CCDC36
- Application
-
Alternative Names
Cancer/testis antigen 74 ;CT74
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IYA8
-
Expression Region
11-592aa
-
Molecular Weight
80.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC36, or Coiled-Coil Domain Containing 36, is a protein that has garnered interest in recent years due to its potential roles in various biological processes and its implications in human health. It belongs to a larger family of coiled-coil domain proteins, which are known to be involved in protein-protein interactions, cellular structure, and signal transduction. Research has suggested that CCDC36 may play a critical role in cellular functions such as proliferation, differentiation, and apoptosis, although its exact mechanisms remain poorly understood. Studies have linked dysregulation of CCDC36 expression to certain diseases, including cancer, indicating its relevance as a potential biomarker or therapeutic target. Furthermore, the reconstitution of CCDC36 in vitro allows scientists to explore its function and interactions within cellular pathways, enabling a better understanding of its biological significance. As such, the recombinant expression and characterization of CCDC36 can provide valuable insights into its functional roles, aid in the identification of interaction partners, and facilitate the development of strategies for modulating its activity in disease contexts. Overall, research into CCDC36 holds promise for uncovering novel insights into complex cellular mechanisms and potential avenues for therapeutic intervention.
